Journal
FRONTIERS IN PHARMACOLOGY
Volume 13, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2022.1007790
Keywords
angiogenesis inhibitors; Tagetes minuta; alpha-terthienylmethanol; protein kinase C isozymes; molecular docking; molecular dynamics
Categories
Funding
- Catholic University of Cordoba
- CONICET
- FONCyT
- Fundacion Roemmers [PICT 2017-1262, PICT 2017-1381, PICT 2019-2019-00721, PICT-2020-SERIEA-01627]
Ask authors/readers for more resources
This study explores flora from Argentina as a source of new chemical entities with antiangiogenic activity. It identifies α-terthienylmethanol in T. minuta as a promising antiangiogenic phytochemical with potential implications in fighting against various types of cancer.
Background: Tumor angiogenesis is considered as a crucial pathologic feature of cancer with a key role in multidrug resistance (MDR). Adverse effects of the currently available drugs and the development of resistance to these remain as the hardest obstacles to defeat. Objetive: This work explores flora from Argentina as a source of new chemical entities with antiangiogenic activity. Methods: Tube formation assay using bovine aortic endothelial cells (BAECs) was the experiment of choice to assess antiangiogenic activity. The effect of the pure compound in cell invasiveness was investigated through the trans-well migration assay. The inhibitory effect of the pure compound on VEGFR-2 and PKC isozymes alpha and beta 2 activation was studied by molecular and massive dynamic simulations. Cytotoxicity on peripheral blood mononuclear cells and erythrocyte cells was evaluated by means of MTT and hemolysis assay, respectively. In silico prediction of pharmacological properties (ADME) and evaluation of drug-likeness features were performed using the SwissADME online tool. Results: Among the plants screened, T. minuta, showed an outstanding effect with an IC50 of 33.6 +/- 3.4 mu g/ml. Bio-guided isolation yielded the terthiophene alpha-terthienylmethanol as its active metabolite. This compound inhibited VEGF-induced tube formation with an IC50 of 2.7 +/- 0.4 mu M and significantly impaired the invasiveness of bovine aortic endothelial cells (BAECs) as well as of the highly aggressive breast cancer cells, MDA-MB-231, when tested at 10 mu M. Direct VEGFR-2 and PKC inhibition were both explored by means of massive molecular dynamics simulations. The results obtained validated the inhibitory effect on protein kinase C (PKC) isozymes alpha and beta 2 as the main mechanism underlying its antiangiogenic activity. alpha-terthienylmethanol showed no evidence of toxicity against peripheral blood mononuclear and erythrocyte cells. Conclusion: These findings support this thiophene as a promising antiangiogenic phytochemical to fight against several types of cancer mainly those with MDR phenotype.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available